Cargando…
Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand
Peanut allergy is a growing health concern that can cause mild to severe anaphylaxis as well as reduced quality of life in patients and their families. Oral immunotherapy is an important therapeutic intervention that aims to reshape the immune system toward a higher threshold dose reactivity and sus...
Autores principales: | Wanniang, Naphisabet, Boehm, Theresa-Maria, Codreanu-Morel, Françoise, Divaret-Chauveau, Amandine, Assugeni, Isabela, Hilger, Christiane, Kuehn, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577271/ https://www.ncbi.nlm.nih.gov/pubmed/37849958 http://dx.doi.org/10.3389/falgy.2023.1270344 |
Ejemplares similares
-
Relevance of sensitization to legumes in peanut‐allergic children
por: Muller, Timé, et al.
Publicado: (2022) -
Novel, computational IgE‐clustering in a population‐based cross‐sectional study: Mapping the allergy burden
por: Czolk, Rebecca, et al.
Publicado: (2023) -
Allergenic risk assessment of cowpea and its cross‐reactivity with pea and peanut
por: Chentouh, Mouhamed Mounir, et al.
Publicado: (2022) -
Transitioning peanut oral immunotherapy to clinical practice
por: Lazizi, S., et al.
Publicado: (2022) -
Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)